Table of Contents Table of Contents
Previous Page  559 / 1082 Next Page
Information
Show Menu
Previous Page 559 / 1082 Next Page
Page Background

S544

ESTRO 36 2017

_______________________________________________________________________________________________

surface molecules CD14, CD83, CD80, CD86 and HLA-DR via

flow cytometry. Functional analysis of irradiated DCs was

performed through FITC-labelled phagocytosis assay.

Results

No major significant changes in the immune profile during

differentiation of monocytes (CD14

high

, CD83

low

, CD86

low

,

CD80l

ow

, HLA-DR

high

) into iDCs (CD83

low

, CD86

low

,

CD80

medium

, HLA-DR

medium

) and mDCs (CD83

high

, CD86

high

,

CD80

high

, HLA-DR

high

) were seen after treatment with

different radiation doses (1x15 Gy, 5x2 Gy, 1x0.5 Gy)

compared to the untreated control group. Functional

analysis showed no difference in the phagocytotic capacity

of irradiated iDCs and macs compared to the control

group.

Conclusion

Our experiments reveal that after irradiation with

different fractionations and doses maturation of DCs was

unchanged compared to the control group. The capability

for phagocytosis was unaffected after irradiation of DCs,

indicating persistent functionality of the immune system.

Additional RT-induced effects on the immunogenic

potential of DCs will be investigated by using further

functional assays (migration assay, mixed lymphocyte

reaction assay). To investigate the effect of particle

therapy, DCs will be irradiated with protons and carbon

ions (C12) in future experiments.

PO-0994 Integrin antagonistic drugs reveal different

effectiveness in 2D monolayer vs. 3D spheroid culture

V. Kopatz

1,2

, E. Selzer

1

, W. Dörr

1,2

1

Medical University of Vienna, Department for Radiation

Oncology, Vienna, Austria

2

Medical University of Vienna, Christian Doppler Lab for

Medical Radiation Research for Radiooncology, Vienna,

Austria

Purpose or Objective

Preclinical evaluation of novel therapeutic substances, as

well as the assessment of radiation effects, is frequently

performed under standard 2D cell culture conditions.

However, such monolayer cultures may fail with regard to

representation of morphological in vivo conditions and

their (radio)biological consequences. An alternative, in

the latter aspect is the use of 3D in vitro models - like

tumor spheroid culture - which are of intermediate

complexity between standard in vitro monolayer cultures

and in vivo tumor models. In spheroid culture, tumor cells

grow in 3D aggregates that display greater similarity to in

vivo tumor architecture and growth conditions, such as the

presence of oxygen and nutrient gradients as well as more

complex cellular interactions or 'in vivo-like” gene

expression profiles. Depending on their size, multicellular

spheroids may also display central hypoxic and/or necrotic

areas and show quiescent and proliferating

compartments. Thus spheroids often depict different

behavior and sensitivity towards certain drugs or

radiotherapeutic treatment as cells cultured as 2D

monolayers. Especially for the study of surface receptors

like integrins the 3D structure and environment is a critical

aspect as these receptors transduce signals from the

extracellular space to the inside, thus influencing

different cell signaling pathways like cell survival,

proliferation and invasion.

Material and Methods

Therefore in addition two standard 2D cell culture, 3D

spheroid models were established with 518A2 and other

melanoma cell lines for evaluation of their response to two

different integrin antagonists, cilengitide and a novel

integrin antagonist (NIA), as well as for the

characterization of the effects of radiation treatment

alone or in combination with the drugs.

Results

While in 2D cultures of 518A2 melanoma cells, the

comparator substance cilengitide showed to be more

efficient than our novel compound NIA (IC50 value of

0,65µM), it had no inhibitory effect in 3D spheroid culture

up to 50µM. Comparatively NIA revealed to have similar

effectiveness in 2D as well as 3D cultures, both in the low

micromolar range. During monitoring of spheroid growth,

NIA treated spheroids initially depicted a growth

retardation, before cells started to disintegrate and die.

The radiosensitivity of 518A2 melanoma cells was found to

be similar in both culture conditions.

Conclusion

Similar differences in drug response and efficacy between

2D and 3D cell culture environments have been reported

for various anti-cancer substances as well as for some

radiation exposure endpoints. However, other endpoints

may - in a treatment-related manner - be depending on

the culture system used. We thus plan to perform further

comparative studies on survival-dependent aspects

(apoptosis, intracellular signaling, and others) with

integrin antagonists alone as well as in combination with

irradiation in 2D cell culture versus 3D spheroids.

PO-0995 Estimation of radiobiology parameters of

infiltrative low-grade gliomas WHO Grade II.

S. Milyukov

1

, Y. Lysak

2

, G. Panshin

2

, N. Kharchenko

1

, Z.

Tsallagova

2

, T. Izmailov

2

1

Peoples’ Friendship University of Russia, Department of

oncology and roentgenoradiology, Moscow, Russian

Federation

2

Russian Scientific Center of Roentgenoradiology of

Russia, Research department of innovative technologies

of radiotherapy and chemoradiation treatment of

malignant tumors, Moscow, Russian Federation

Purpose or Objective

Determine the value of radiobiological parameters of

infiltrative low-grade gliomas WHO Grade II

Material and Methods

In total (the data from) 5 clinical studies: EORTC 22844

(Karim AB et al., 1996.), EORTC 22845 (van den Bent MJ

et al., 2005), NCCTG 86-72-51 (Shaw E et al., 2002), the

RTOG 9802 (Shaw EG et. al., 2012), the study on the

hyperfractionated radiotherapy (Jeremic B et. al., 1998),

and selected data from our database were used for the

calculation radiobiological parameters of LGG. In total,

our study included 870 patients. All patients received

surgery (1-phase treatment) and radiotherapy (2-phase

treatment). Following radiobiological parameters of

radiotherapy were used for the calculation: dose per

fraction, total dose of radiotherapy, total number of

treatment days, 5-year progression-free survival.

Results

Following radiobiological parameters of infiltrative low-

grade gliomas WHO Grade II were calculated: α, β, α/β,

Td, D prolif, Tk, N clonogens. Following values were

calculated (95% Cl): α (Gr

– 1

) = 0,096 (0,08–0,11), β (Gr

–2

)

= 0,014 (0,012-0,018), α/β (Gr) = 6,8 (4,3-9,2), T

d

(days) =

21,3 (18,3-26,4), D

prolif

(Gr) = 0,27 (0,21-0,35), T

k

(days) =

44 (34-55), N

clonogens

= 2,18·10

3

(1,2-5,3) ·10

3

.

Conclusion

The calculated values of radiobiological parameters give a

better idea of the biological properties of the low-grade

gliomas and estimate as accurately as possible of the total

dose of radiotherapy using a linear-quadratic model.

Poster: RTT track: Patient preparation, positioning and

immobilisation

PO-0996 Accuracy of an optical surface monitoring

device to reduce daily imaging of breast cancer

patients

J. Sharpe

1

, A. Tini

1

, A. Moreira

1

, I. Pytko

1

, C. Winter

1

, M.

Guckenberger

1

, C. Linsenmeier

1

1

University Hospital of Zurich, Radiation Oncology Clinic,

Zurich, Switzerland